Comments
Loading...
MannKind (MNKD) Forecast
NewsEarningsMannKind (MNKD) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestMannKind (NASDAQ:MNKD) Stock Quotes, Forecast and News Summary
MannKind Stock (NASDAQ: MNKD) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy MannKind (MNKD) stock?
You can purchase shares of MannKind (NASDAQ:MNKD) through any online brokerage.
Who are MannKind (MNKD) competitors?
Other companies in MannKind’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Centessa Pharmaceuticals (NASDAQ:CNTA), Xencor (NASDAQ:XNCR), Arrowhead Pharma (NASDAQ:ARWR) and Kiniksa Pharmaceuticals (NASDAQ:KNSA).
What is the forecast, or price target, for MannKind (MNKD) stock?
MannKind has a consensus price target of $8.29.
What is the current price for MannKind (MNKD)?
The stock price for MannKind (NASDAQ: MNKD) is $6.89 last updated November 22, 2024 at 2:18 PM EST.
Does MannKind (MNKD) pay a dividend?
There are no upcoming dividends for MannKind.
When is MannKind (NASDAQ:MNKD) reporting earnings?
MannKind’s Q3 earnings are confirmed for Thursday, November 7, 2024.
Is MannKind (MNKD) going to split?
There is no upcoming split for MannKind.
What sector and industry does MannKind (MNKD) operate in?
MannKind is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.